Top compounds associated with response to MTRNR2L11


Feature Type Standardized
Nominal ANOVA
mRNA Bortezomib CTRPv2 pan-cancer AAC 0.053 0.1
mRNA VER-155008 CTRPv2 pan-cancer AAC 0.054 0.1
mRNA Erlotinib UHNBreast pan-cancer AAC 0.43 0.1
mRNA Compound 7d-cis CTRPv2 pan-cancer AAC 0.054 0.1
mRNA Gemcitabine CTRPv2 pan-cancer AAC 0.048 0.1
mRNA selumetinib:vorinostat (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.052 0.1
mRNA brivanib CTRPv2 pan-cancer AAC 0.051 0.1
mRNA MLN2238 CTRPv2 pan-cancer AAC 0.049 0.1
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.047 0.2
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.046 0.2
Download CSV